GE HealthCare Technologies (NASDAQ:GEHC) Research Coverage Started at Hovde Group

Hovde Group started coverage on shares of GE HealthCare Technologies (NASDAQ:GEHC) in a research report released on Friday morning,Benzinga reports. The brokerage issued a market perform rating and a $14.00 price objective on the stock.

A number of other research analysts also recently commented on the stock. Wells Fargo & Company dropped their price objective on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research note on Thursday, April 30th. BTIG Research reissued a “buy” rating and issued a $75.00 target price on shares of GE HealthCare Technologies in a research report on Monday, July 13th. JPMorgan Chase & Co. lowered their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a report on Thursday, April 30th. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, March 21st. Ten research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $76.41.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $63.07 on Friday. The firm has a market cap of $28.69 billion, a P/E ratio of 15.09, a price-to-earnings-growth ratio of 1.72 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22. GE HealthCare Technologies has a 1 year low of $58.75 and a 1 year high of $89.77. The firm’s 50 day moving average price is $63.64 and its 200 day moving average price is $71.89.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the firm posted $1.01 earnings per share. The company’s revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, sell-side analysts anticipate that GE HealthCare Technologies will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

Insider Buying and Selling

In other news, Director Rodney F. Hochman acquired 1,618 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were bought at an average price of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Kevin Lobo bought 10,000 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 22nd. The shares were purchased at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the transaction, the director owned 14,363 shares of the company’s stock, valued at approximately $921,817.34. This represents a 229.20% increase in their position. The SEC filing for this purchase provides additional information. Insiders have acquired 21,847 shares of company stock valued at $1,361,355 over the last three months. Company insiders own 0.36% of the company’s stock.

Institutional Investors Weigh In On GE HealthCare Technologies

Several hedge funds and other institutional investors have recently added to or reduced their stakes in GEHC. Wedge Capital Management L L P NC boosted its position in GE HealthCare Technologies by 27.8% in the 2nd quarter. Wedge Capital Management L L P NC now owns 461,283 shares of the company’s stock valued at $29,527,000 after buying an additional 100,462 shares during the last quarter. Northside Capital Management LLC grew its stake in shares of GE HealthCare Technologies by 26.5% during the second quarter. Northside Capital Management LLC now owns 241,923 shares of the company’s stock valued at $15,485,000 after acquiring an additional 50,634 shares in the last quarter. Investors Research Corp purchased a new stake in shares of GE HealthCare Technologies during the second quarter worth about $288,000. Tema ETFs LLC increased its position in shares of GE HealthCare Technologies by 10.4% during the second quarter. Tema ETFs LLC now owns 9,214 shares of the company’s stock worth $590,000 after acquiring an additional 870 shares during the last quarter. Finally, Generali Investments Management Co LLC lifted its stake in shares of GE HealthCare Technologies by 5.1% in the second quarter. Generali Investments Management Co LLC now owns 6,098 shares of the company’s stock worth $390,000 after acquiring an additional 298 shares in the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.